Clinical Trial Update: Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured

View source ↗

Summary

Clinical trial update evaluating how the HBV ELISPOT assay performs in detecting T-cell immune responses in patients with hepatitis B infection or after cure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hepatitis B | Status: COMPLETED